Healthy adult males
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study 2) 20-30 year old men 3) Subjects with BMI within normal range (18.5 kg/m2 =< BMI < 25.0 kg/m2)
Exclusion criteria
Exclusion criteria: 1) Those who were administered ''drug'', such as H2 blocker, PPI, or digestive enzyme preparation, ''medicated products'', such as stomach medicine or digestive drugs, or ''supplement'' containing amino acids or protein, which may have effects on the protein absorption, within one month before the first administration of intervention or control food, or during this study. 2) Patients with diabetes mellitus 3) Patients with diseases or symptoms undergoing treatments 4) Those who may suffer from food allergy 5) Those who may suffer from lactose intolerance 6) Those who have smoking habits 7) Those who donated 200 mL or 400 mL of blood within one month or three months before giving written informed consent, respectively 8) Those who were included other clinical trials within one month before the first administration of intervention or control food, or during this study. 9) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the blood amino acid areas under the curve (AUC) (total amino acids, essential amino acids, leucine, BCAA) | — |
Secondary
| Measure | Time frame |
|---|---|
| the maximum (Cmax) blood amino acid level (total amino acids, essential amino acids, leucine, BCAA) Blood amino acid level at each blood collection time point (total amino acids, essential amino acids, leucine, BCAA) the time to maximum concentration (Tmax) of amino acids (total amino acids, essential amino acids, leucine, BCAA) | — |
Countries
Japan
Contacts
Meiji Co., Ltd. R&D Total Oversight Department, R&D Division